Abstract Loop diuretics such as bumetanide and furosemide enhance aminoglycoside ototoxicity when co-administered to patients and animal models. The underlying mechanism(s) is poorly understood. We investigated the effect of these diuretics on cellular uptake of aminoglycosides, using Texas Red-tagged gentamicin (GTTR), and intracellular/whole-cell recordings of Madin-Darby canine kidney (MDCK) cells. We found that bumetanide and furosemide dose-dependently enhanced cytoplasmic GTTR fluorescence by *60 %. alone hyperpolarized the cells by *-14 mV, reduced the I/V slope with a net current V r near -10 mV, and inhibited GTTR uptake by *50 %. In the presence of La 3? , bumetanide-caused negligible change in potential or I/ V. We conclude that NSCCs constitute a major cell entry pathway for cationic aminoglycosides; bumetanide enhances aminoglycoside uptake by hyperpolarizing cells that increases the cation influx driving force; and bumetanideinduced hyperpolarization is caused by elevating intracellular Ca 2? and thus facilitating activation of the intermediate conductance Ca 2? -activated K ? channels.
clotrimazole, but not by tetraethylammonium (TEA), 4-aminopyridine (4-AP) or glipizide, nor by Cl -channel blockers diphenylamine-2-carboxylic acid (DPC), niflumic acid (NFA), and CFTR inh -172. Bumetanide and furosemide hyperpolarized MDCK cells by *14 mV, increased whole-cell I/V slope conductance; the bumetanide-induced net current I/V showed a reversal potential (V r ) *-80 mV. Bumetanide-induced hyperpolarization and I/V change was suppressed by Ba 2? or clotrimazole, and absent in elevated [Ca 2? ] i , but was not affected by apamin, 4-AP, TEA, glipizide, DPC, NFA, or CFTR inh -172. Bumetanide and furosemide stimulated a surge of Fluo-4-indicated cytosolic Ca 2? . Ba 2? and clotrimazole alone depolarized cells by *18 mV and reduced I/V slope with a net current V r near -85 mV, and reduced GTTR uptake by *20 %. La 3? alone hyperpolarized the cells by *-14 mV, reduced the I/V slope with a net current V r near -10 mV, and inhibited GTTR uptake by *50 %. In the presence of La 3? , bumetanide-caused negligible change in potential or I/ V. We conclude that NSCCs constitute a major cell entry pathway for cationic aminoglycosides; bumetanide enhances aminoglycoside uptake by hyperpolarizing cells that increases the cation influx driving force; and bumetanideinduced hyperpolarization is caused by elevating intracellular Ca 2? and thus facilitating activation of the intermediate conductance Ca 2? -activated K ? channels.
Keywords Aminoglycoside Á Ototoxicity Á Loop diuretics Á Membrane potential Á Ion current Á Chloride channels Á Cytosolic calcium 
Introduction
Loop diuretics, such as bumetanide or furosemide, enhance the ototoxicity of aminoglycoside antibiotics when these two classes of drugs are co-administered to mammals including humans [1] [2] [3] . Current limited knowledge leads us to hypothesize that this synergism involves pharmacological summations and pharmacodynamic interactions. Loop diuretics themselves are ototoxic at high doses, and can cause either a temporary, or in some cases, a permanent hearing loss in patients. In animal models, these drugs induce edema in the stria vascularis, a decrease of the endocochlear potential and a temporary loss of auditory function [4, 5] . Loop diuretic-induced edema in the stria vascularis is dependent on Na ? extrusion into the intra-strial space by Na ? /K ? -ATPase activity at the basolateral membranes of marginal cells and the presence of Na ? in perilymph [6, 7] . Loop diuretics are well-known inhibitors of Na ? /2Cl -/K ? cotransporter (NKCC) [8] . Therefore, loop diuretic-induced edema is thought to be due to an imbalance between the NKCC and Na ? /K ? -ATPase activities in strial marginal cells, but the exact mechanism is not clear. The synergistic pharmacotoxicology of loop diuretics with aminoglycoside antibiotics remains to be determined.
Cochlear and vestibular hair cells, as well as kidney proximal tubule cells, are particularly susceptible to aminoglycoside toxicity once the drug enters the cell, leading to cell death and subsequent deafness, vestibular deficits, and/or kidney dysfunction [2, [9] [10] [11] . Aminoglycosides are lipid-insoluble multivalent cations that can rapidly enter sensory hair cells via their mechanoelectrical transduction (MET) channels and less rapidly by endocytosis at the apical membrane [12] [13] [14] . On the other hand, aminoglycoside influx through hair cell basolateral membrane appears to be negligible [14] [15] [16] . Systemically administered aminoglycosides predominantly cross the multi-layered, cell-based blood-labyrinth barrier (BLB) in the stria vascularis to enter cochlear endolymph and hair cells to exert their ototoxicity [13, 16] . Loop diuretics have long been known to increase the entry of systemically administered aminoglycosides into cochlear endolymph [17] , suggesting that loop diuretics enhance the trafficking of aminoglycosides across the strial BLB. Based on this mechanism, one plausible pharmacotherapeutic strategy to prevent aminoglycoside-induced ototoxicity is to selectively block aminoglycoside trafficking across the strial BLB while maintaining serum levels of aminoglycosides for bactericidal activity. Understanding the cellular mechanisms for trafficking aminoglycosides across the strial BLB is a prerequisite for developing this strategy.
The most direct pathway between the vasculature and endolymph is trafficking across the strial BLB. This barrier is composed at minimum of two cell layers: capillary endothelial cells and marginal cells, but little is known about what regulates aminoglycoside trafficking across their cellular membranes. One potential mechanism is endocytosis and exocytosis [14, 18] . Another is permeation through non-selective cation channels (NSCCs) such as the MET channel and TRP channels, as for fluorescent dyes like FM1-43 [3, 12, 19, 20] . Aminoglycoside permeation by NSCC is also supported by our studies on Madin-Darby canine kidney (MDCK) cells and other kidney epithelial cell lines using Texas Red-tagged gentamicin (GTTR). When endocytosis was suppressed by low temperature, cellular uptake of GTTR was still present; and the uptake of GTTR was inhibited by high K ? -induced depolarization and by TRPV channel blockers [21, 22] . GTTR uptake is also correlated to expression of functional TRPV4 [23] . The entry of GTTR into hair cells can be stimulated by TRPA1 agonists [20] , further supporting the hypothesis that aminoglycosides can permeate NSCCs with a sufficiently large pore diameter. Like native gentamicin, systemic GTTR enters cochlea and is toxic to hair cells [13, 24] .
MDCK cells are a widely used epithelial cell line with many similarities to strial marginal cells in function and expression of NKCCs, Na ? /K ? -ATPase, and ion channels [25] . This study used MDCK cells as a cell model to identify cellular mechanisms underlying loop diuretic modulation of cellular uptake of aminoglycosides.
We hypothesized that loop diuretics enhance cellular uptake of aminoglycosides by: (i) activating aminoglycosidepermeant ion channels and/or (ii) hyperpolarization-potentiation of the electrophoretic driving force for cationic aminoglycoside influx through permeant ion channels. We tested this hypothesis by measuring cytosolic GTTR fluorescence and by analyzing membrane potentials and currents. Our data support the second hypothesis: that bumetanide and furosemide enhance cellular uptake of aminoglycosides through NSCCs by hyperpolarizing MDCK cells via activation of intermediate conductance Ca 
/Cl
-co-transporters and aquaporins [26] .
Methods

Conjugation and Purification of GTTR
An excess of gentamicin (in K 2 CO 3 , pH 10) was mixed with Texas Red (TR) succinimidyl esters (Invitrogen, CA) [27] and, from the reaction mixture, the conjugate (GTTR) was separated from unconjugated gentamicin and potential contamination of unreacted TR by reversed phase chromatography using C-18 columns (Burdick and Jackson, Muskegon, MI) [21, 28] . The isolated GTTR conjugate was aliquoted, lyophilized, and stored desiccated, in the dark at -20°C until required.
Cell Culture MDCK cells were cultured in antibiotic-and phenol redfree Dulbecco's minimal essential medium (MEM, Invitrogen, CA) with 10 % fetal bovine serum at 37°C with 5 % CO 2 . These cells were a subclone of the parental cell line initially used to reduce the heterogeneity [21] . For GTTR experiments, cells were seeded into eight-well cover-glass chambers (ISC BioExpress) at 3,000 cells/well and grown for 24 h, when cells had become *90 % confluent and had developed tight junctions. For electrophysiological experiments, cells were seeded into glassbottomed 35 mm Petri dish for *24 h allowing the cells to attach to the bottom glass and grow to *10 or 90 % confluent for single-cell patch recordings or sharp electrode conventional intracellular recordings, respectively.
GTTR Uptake and Pixel Intensity Analysis
MDCK cells cultured to *50 % confluent (18-22 h after plating) on chambered cover-slips were washed three times with aerated normal extracellular solution (NES) containing (in mM): NaCl 138, KCl 5, CaCl 2 1.6, MgCl 2 1.2, Na-HEPES 5, HEPES 6, glucose 7.5, with pH 7.4 and osmolarity of 300 mOsm L -1 , and then treated with GTTR (5 lg mL -1 in NES) for 30 s as the control. We confirmed previously that the GTTR fluorescent signal in MDCK cells is proportionate to the incubation duration and dose; and that a 30 s incubation at room temperature minimized GTTR uptake by endocytosis [21, 28] . Cellular loading of GTTR was also tested with pretreatments of (i) bumetanide or furosemide (1-100 lM) in NES for 3-10 min, (ii) ion channel blocking agents such as La 3? , Ba 2? , TEA, 4-AP, clotrimazole, DPC, NFA, etc., for 3 min, (iii) ion channel blocking agents with 10 lM bumetanide for 3 more min, immediately followed by 30 s incubation with GTTR (5 lg/mL) in each pretreatment solution. After GTTR incubation, cells were washed three times in NES, then fixed and delipidated with 4 % formaldehyde plus 0.5 % Triton X-100 (FATX) for 45 min [21] . Following fixation, cells were thoroughly rinsed with phosphate-buffered saline (PBS, Invitrogen, CA) prior to confocal imaging.
All GTTR specimens were imaged directly on the chambered cover-slip using a Bio-Rad MRC 1024 ES laser scanning confocal system attached to a Nikon Eclipse TE300 inverted microscope. GTTR images were acquired using 1024 9 1024 pixel box size using a 60 9 lens (n.a. 1.4) with an xy resolution = 230 nm and xz resolution = 440 nm. All specimens from the same experiment were imaged at the same laser intensity and gain settings. Representative images from each experiment were identically prepared using Adobe Photoshop. Optical sections from each experimental set were manually segmented for cytoplasmic pixel intensity determination (ImageJ, NIH) (supplemental Fig. 1 [sFig. 1] ). GTTR fluorescence is largely localized in the cytosol when compared to nucleolus and the nucleoplasm, with the typical pixel intensity of 184 ± 17.7, 175 ± 30.4, and 125 ± 25.8 (p \ 0.001, n = 46) in arbitrary units, and occupies 58, 5, and 37 % of the total pixels (area), respectively. To minimize error, quantification of GTTR uptake was limited to the cytosol (cellular pixels minus nuclear pixels). The intensity mean and SE of the mean was normalized against the standard (control data) in the same experimental set. Student's t test was used to determine any significant difference between treatment groups.
Imaging Analysis of Intracellular Ca 2? MDCK cells at *50 % confluency on 18 mm round glass coverslips were preloaded with the fluorescent dye Fluo-4 (4.6 lM in culture media) for 60 min at room temperature. The coverslip was clamped into a magnetic chamber system (Chamlide CMB, Quorum Canada); excess Fluo-4 was washed away and the chamber was filled with 1 mL normal extracellular solution (NES). Images were acquired on a Hamamatsu OrcaER CCD camera every 5 s over 15 min with a Yokogawa CSU10 spinning disk confocal system with focus drift correction (Nikon TE2000 PFS). Laserbased 488-nm excitation was combined with filter-based emission detection (500-550 nm). Image data acquisition under control conditions began after locating cells (Fig. 8A) akin to those used for electrophysiology. The final concentration of bumetanide (10 lM) application was achieved by replacing 0.5 mL NES with an equal volume of 20 lM bumetanide in NES (Fig. 8B) . Fiji/ImageJ software was used for data quantitation and analysis.
RT-PCR
Total RNA was extracted from MDCK cells using RNeasy Mini kit (Qiagen), and first-strand cDNA was synthesized from 5 lg of total RNA using SuperScript First-Strand Synthesis System for RT-PCR (Invitrogen). For PCR, 0.5 lL of the reverse-transcribed cDNA was used in each reaction catalyzed by AmpliTaq DNA polymerase (Applied Biosystems). The sequence information of the primers used is available in Supplementary data (sFig. 6). The PCR condition used is an initial 95°C incubation for 2 min followed by 40 cycles of 95°C for 30 s, 60°C for 30 s, and 72°C for 1 min for all reactions. PCR was performed in an Applied Biosystems thermal cycler. PCR products were analyzed by electrophoresis in 2 % agarose gel.
Intracellular and Tight-Seal Whole-Cell Recordings
Conventional intracellular recordings were conducted on 90 % confluent MDCK cells in a glass-bottomed 35-mm culture dish continuously superfused with a HEPES-buffered NES (see above for composition) at 35°C, the same solution for GTTR uptake analysis and whole-cell recording. A molded silicon rubber block was placed in the culture dish to form a bathing chamber sized \0. 5 ? -acetate with a tip resistance of 60-120 MX, intracellular penetration was obtained with assistance of a micromanipulator (MP-1 Narishige, Japan). The membrane potential (V m ) was monitored by an Axoclamp 2B preamplifier (Molecular Device, Inc. USA) in current-clamp bridge mode. No current injection was employed. Electrical signals were recorded on a PC computer equipped with pClamp9 software (Molecular Device) using sampling intervals of 2 ms. The initial V m was determined by the voltage jump at the penetration plus *5 min stabilization thereafter, and confirmed by the voltage jump upon dislodge of the electrode as we did previously [29] .
Conventional and perforated patch whole-cell voltageand current-clamp experiments were conducted mostly on single or small clustered two or three MDCK cells at room temperature with assistance of Axopatch 1-D preamplifier, Digidata 1322A digitizer and pClamp9 software. The method of conventional whole-cell recording was similar to that published previously [30, 31] . In brief, the glass micropipette of *1 lm tip (4-7 MX) was filled with a normal internal solution (NIS) containing (in mM): K-gluconate 130, NaCl 10, CaCl 2 2.0, MgCl 2 1.2, HEPES 10, EGTA 5 (free Ca 2? =118 nM) and glucose 7.5 (pH 7.2 and 290 mOsm L -1 ). For an elevated Ca 2? internal solution (hiCaIS), the EGTA was removed, CaCl 2 was reduced to 2 lM and 8 mM K-gluconate was added to bring up osmolarity back to 290 mOsm L -1 . A ''salt bridge'' was routinely used for the reference electrode constructed with Ag/AgCl wire in 4 % agar/2 M KCl gel. The liquid junction potential of the electrodes filled with NIS and hiCaIS was 14.3 and 15.1 mV, respectively, in the NES bathing solution, calculated by a tool in pClamp9 software. The liquid junction potential value was used to correct V m values during off-line data analysis or in setting of on-line correction for conventional whole-cell recording experiments [32] .
Whole-cell configuration was achieved by applying negative pressure to rupture the membrane at the tip of an electrode pipette when a giga-ohm seal was obtained. For perforated patch, the pipette was back-filled with a freshly made solution of nystatin (200 lg mL , etc.) but not to Cl - [33] . Successful whole-cell configuration was indicated by an access resistance between 10 and 20 MX for conventional and 20-80 MX for perforated patch. The access resistance (R a ) was compensated off-line as described previously [31] . The input capacitance (C input ) was not compensated online in order to monitor the access resistance change and to calculate off-line the C input [30] . The current and voltage signals data were filtered at 5 kHz (-3 dB) and digitally recorded in a computer at sampling intervals of 10, 20, 100 ls as needed. A simultaneous gap-free recording was carried out by a Minidigi digitizer and Axoscope 9.2 software at a sampling interval of 50 ms. The input conductance (G input ) was measured by 20 mV step-induced steady-state current or the I/V slope between -40 and -60 mV.
Drug Application
Drugs at known concentrations or bathing solutions with different ionic compositions were applied by superfusion of cells within the petri dish. The distance from the tube mouth to the recorded cell was *150 lm in whole-cell experiments. The exchange of solutions was achieved in seconds by switching the solution reservoirs without affecting the superfusion speed or bath temperature; but for in intracellular recording setting, it took *30 s for new solution to reach the bath and 2 min to complete the solution exchange. The drugs used in this study include acetylcholine (ACh), bumetanide (BUM), CFTR inh -172 (CF172, a gift from Cystic Fibrosis Foundation, USA) [34] , clotrimazole (CLT), chromanol 293B, diphenylamine-2-carboxylic acid (DPC), Fluo-4 (Invitrogen, USA), furosemide (FUR, Hospira Incorp, USA), glipizide (Glip), gramicidin, niflumic acid (NFA), nitrendipine (NTDP), tetraethylammonium chloride (TEA), 4-aminopyridine (4-AP), all from Sigma, USA, unless indicated otherwise.
Results
Loop Diuretics Increase Cellular Uptake of GTTR
Exposure of MDCK cells to bumetanide increased intracellular GTTR fluorescence in most cells (n = 24 wells from 6 experiments) and this enhanced fluorescence was bumetanide concentration-dependent (Fig. 1A, C) . The GTTR fluorescence was maximally increased by 100 lM bumetanide to 170 ± 15 % of control values. Higher concentrations of bumetanide caused more variable fluorescence intensities, probably due to nonspecific actions on the cells. Furosemide also increased cytoplasmic GTTR fluorescence in a dose-dependent manner (Fig. 1B, C) . Hill equation fitting of the data in Fig. 1C , D revealed an EC 50 of 0.51 ± 0.066 and 1.6 ± 0.58 lM for bumetanide and furosemide, respectively. Therefore, we used sub-maximum dose of 10 lM bumetanide and 30 lM furosemide for quantitative analysis of their membrane actions.
To test whether bumetanide-enhanced fluorescence was due to a decrease in intracellular Cl -level caused by bumetanide inhibition of NKCC [8] , GTTR uptake was compared between 3 and 10 min pre-incubation of bumetanide. Results showed no significant difference between these two treatment groups (-13.1 ± 3.2 vs. 12.8 ± 3.9 mV, n = 6 each, p [ 0.05; see Discussion). GTTR uptake [22] . In this study, we observed that La 3? at 1 mM inhibited GTTR uptake by 48 ± 2.1 % (Fig. 2) . La 3? inhibition on GTTR uptake was dose-dependent in the range of 0.05-1 mM; 5 mM La 3? caused a slight lower inhibition (41 ± 4.2 %, p [ 0.05 when compared to 1 mM). In the presence of 0.1 and 1 mM La 3? , 10 lM bumetanide had no significant effect on cellular uptake of GTTR, indicating that bumetanide failed to overcome La 3? inhibition of GTTR uptake.
In conventional intracellular recording experiments, La 3? (0.1 and 1 mM) hyperpolarized the majority of cells in a dose-dependent manner (-3.7 ± 0.75 and -14 ± 4.7 mV, n = 3 and 8, respectively; Fig. 3A ), suggesting that a La 3? -sensitive NSCC conductance played a substantial role in determining V m in these subconfluent MDCK cells.
In whole-cell recordings from single or small clusters of tightly coupled MDCK cells (B5 cells), 0.1-5 mM La 3? consistently reduced the slope conductance in entire range of whole-cell I/V curves (Fig. 3D) , which was also associated with a hyperpolarization in V m (zero current potential at the I/V plot, Fig. 3D ). Moreover, in the presence of La 3? , 10 lM bumetanide induced no significant changes in the I/V curves (see below for I/V change and hyperpolarization by bumetanide alone). The I/V curve of La 3? -sensitive net current reversed its polarity at -9.2 ± 4.1 mV (n = 6), consistent with blockade of NSCCs. The input conductance (G input ) was reduced by 1 mM La 3? from 0.83 ± 0.41 to 0.40 ± 0.25 nS in single cells (n = 6, p \ 0.01, paired t test). Multiple cell (2-5 cells) clusters showed a higher control G input and a bigger La 3? -induced G input reduction (e.g., 5 cells in Fig. 3B-D) . Conversely, in the presence of bumetanide, adding La 3? exerted similar inhibition of I/V slope (DG input = -0.31 ± 0.18 nS) as it did when La 3? was given alone (-0.33 ± 0.12 nS, n = 3 each, p [ 0.05).
Taken together, these results support the hypothesis that the NSCC is a major entry route responsible for *50 % of cellular uptake of aminoglycosides. The failure of loop diuretics to overcome La 3? blockade of the NSCCs suggests that the diuretics have little, if any, direct stimulation of the NSCCs, the primary pathway of GTTR uptake. As furosemide (10 lM) has been reported to hyperpolarize MDCK cells by 11 mV [35] , we hypothesized that loop diuretics share this hyperpolarizing effect and, when the aminoglycoside-permeant NSCCs are open, cellular hyperpolarization will increase the electrical driving force and facilitate an influx of the cationic aminoglycosides. The electrophysiological experiments below test this hypothesis and sought to identify the mechanism(s) that underlies loop diuretic-induced hyperpolarization.
Bumetanide Hyperpolarizes Cells and Effects of Selected Channel Blockers on V m and GTTR Uptake
There is a prominent discrepancy in literature regarding the baseline membrane potential of MDCK cells. The MDCK cell membrane potential was reportedly substantially less negative in HEPES-buffered solution (lacking HCO 3 -, -20 to -30 mV) than that in HCO 3 --containing solution (*-50 mV) [36, 37] , and that it was interpreted as that MDCK cells in HEPES buffer lacked K ? -conductance and , bumetanide did not increase in GTTR uptake. the V m is solely set by Cl -conductance. Our initial observations showed otherwise (see below). We measured and compared the V m in five different conditions ( show V m data without distinguishing among the recording conditions unless otherwise noted. A phenomenon worth nothing was that a slow V m oscillation often appeared in cells recorded in Krebs solution with sharp electrode (sFig. 2). The oscillation showed peak-to-peak amplitude of 4-19 mV and a cycle length of 6-8 min which often made a quantitative measurement of drug responses impossible thus we had to limit the use of this method.
Superfusion of 10 lM bumetanide hyperpolarized the majority of cells tested (-13.6 ± 1.6 mV, ranging from 2 to 45 mV, n = 42; Fig. 4 ). Furosemide (30 lM) also hyperpolarized cells (-11.6 ± 6.6 mV, n = 10, sFig. 3A), similar to previous reports [35] . Hyperpolarization occurred after *2 min exposure, often with a fast initial phase followed by a sustained, sometimes oscillatory, phase until termination of drug exposure. Washout with drug-free solution yielded a slow recovery to control V m (Fig. 4) . No continuing increase in hyperpolarization amplitude was observed with prolonged application of bumetanide (up to 15 min), suggesting that any reduction of intracellular [Cl -] i by the loop diuretic did not significantly contribute to this hyperpolarization. Repeated drug application typically caused decreasing amplitude of responses even after washout periods [10 min. Thus, attempts to determine bumetanide dose-hyperpolarization response relationship was unsuccessful due to the rundown of the responses upon repeated applications and a large variability in the induced hyperpolarization among cells.
Bumetanide-induced hyperpolarization was sensitive to selected K ? -channel blockers but not to agents affecting Cl -currents (Fig. 4) . Co-application of 1 mM Ba 2? , a non-specific K ? -channel blocker, or 10 lM clotrimazole, a blocker selective for intermediate conductance Ca 2? -activated K ? -channel (IK), consistently and reversibly suppressed bumetanide-induced hyperpolarization (Fig. 4A) . On the other hand, bumetanide-induced hyperpolarization was not significantly affected by other channel blockers, including 50 nM apamin for small conductance Ca 2? -activated K ? -channel (SK), 10 mM tetraethylammonium (TEA) for large conductance Ca 2? -activated K ? -channels (BK), 10 mM 4-aminopyridine (4-AP, not shown) for voltage-gated K ? -channels (K V ), 0.3 mM diphenylamine-2-carboxylic acid (DPC) non-selectively for anion channels, 10-100 lM NFA for Ca 2? -activated Cl --channels, and 10-30 lM CFTR inh -172 (CF172) for CFTR Cl --channels, nor by a bath solution with Cl -reduced to 60 mM (n = 3-7 in each case).
Several channel blockers alone induced membrane potential changes ( Fig. 5 ; Table 2 ). Of note, 1 mM Ba 2? and elevated (20 mM) K ? consistently induced a 5-20 mV depolarization while chloride channel blockers caused a small (2-5 mV) or negligible hyperpolarization, supporting a notion that the K ? electrochemical force is a major -activated SK and BK channels, respectively, had no effect on the hyperpolarization. B DPC (non-selective anion channel blocker, 0.3 mM), 60 mM low Cl -media, 10 lM CFTR inh 172 (CF, CFTR antagonist), and niflumic acid (NFA, Ca -activated Cl --channel blocker, 0.1 mM) exerted no significant effect on the bumetanide-induced hyperpolarization contributor of the V m negativity in MDCK cells whereas the Cl -electrochemical force normally contributes a few mV depolarization in the membrane potential. Moreover, IK blockers clotrimazole and nitrendipine [38] depolarized the majority (*80 %) of cells tested with variable amplitudes (2-31 mV) whereas little V m change was observed in response to TEA, 4AP, glipizide, and chromanol 293B, suggesting a significant contribution of IK conductance to the membrane potential of the subconfluent MDCK cells. Similar to that reported previously [39] , ACh induced a 2-26 mV hyperpolarization in the majority of cells tested (sFig. 4, n = 6 of 8 cells). The ACh-hyperpolarization was often short-lasting (\2 min), changing to a depolarization during sustained ACh exposure ([2 min). This AChinduced hyperpolarization was largely blocked by 10 lM clotrimazole or 1 lM nitredipine and unmasked a larger depolarization (sFig. 4), substantiating the notion that an IK activation pathway exists in MDCK cells. It is interesting to note that in the presence of 10 lM bumetanide, 10 lM clotrimazole could no longer induce a significant depolarization (Fig. 4A, n = 4) , suggesting a reciprocal antagonism between these two classes of drugs (see more information below).
The effects of these selected channels blockers on GTTR uptake were also consistent with their V m effect: agents causing depolarization tended to reduce cytosolic GTTR fluorescence whereas agents causing hyperpolarization enhanced GTTR fluorescence (Fig. 5) . Ba 2?
(1 mM), clotrimazole (10 lM) and nitrendipine (1 lM, not shown) significantly reduced GTTR uptake. As expected, NFA hyperpolarized the cells and enhanced GTTR uptake ( Fig. 5 ; Table 2 ). Agents with no V m effect exerted no action on GTTR uptake.
Taken together, the above results suggest that bumetanide enhances GTTR uptake by hyperpolarizing cells via activation of a K ? conductance, probably the IK channels. The whole-cell voltage-clamp experiments below further tested this hypothesis.
Bumetanide Activates a K
? -Conductance that is Sensitive to IK-Channel Blockers Bumetanide (10 lM) induced an outward current (5-56 pA) at a holding potential of *-40 mV and an increase in whole-cell I/V slope in the majority of cells tested (Fig. 6) . The G input was increased from 0.88 ± 0.38 to 1.40 ± 0.25 nS (n = 12, p \ 0.01, paired t test) or net increase of 0.48 ± 0.42 nS near -50 mV. The bumetanide-induced net current (Net I -bum ) I/V curves showed a mild outward rectification with a reversal potential at -80 ± 8.2 mV, suggesting activation of a K ? -conductance. In 0.5-5 s step voltage-command-induced currents, the bumetanide-induced net current showed little timedependent changes during the pulses. The activation of whole-cell conductance was partially reversible after drugfree wash for [5 min. The responses exhibited significant rundown with repeated application of bumetanide. Addition of 10 lM clotrimazole (CLT, n = 4), the selective blocker for IK, quickly reversed the bumetanideinduced whole-cell I/V change (Fig. 7) [38, 40] . Similar inhibition was also observed with 1 mM Ba 2? or 1 lM nitrendipine (n = 3 each). On the other hand, 10 mM TEA, 4-AP, and 300 lM DPC did not significantly change the bumetanide-induced I/V changes (n C 3 for each drug). Conversely, in the presence of 10 lM clotrimazole or 1 mM Ba 2? , 10 lM bumetanide no longer induced a significant change of the I/V relation or only a very small response (sFig. 5, n = 6 for each case). Interestingly, in the presence of bumetanide or furosemide, clotrimazole failed to block the K ? conductance to a level below the control and depolarize the cell above its base level (Figs. 4, 7 , sFig. 3); and conversely, in the presence of clotrimazole or Ba 2? , bumetanide no longer induced a significant K ? -conductance and a hyperpolarization (sFig. 5, Figs. 4, 7) . This reciprocal antagonism suggests that bumetanide/furosemide and clotrimazole/Ba 2? act at a common site-perhaps at the gating of the IK channel-in a competitive manner. Results from GTTR uptake experiments (see below, Fig. 9 ) are consistent with this hypothesis.
Furosemide (30-100 lM) also activated I/V slope (sFig. 3, by 0.44 ± 0.62 nS, n = 4) with a net current I/V reversal potential at -81 ± 4 mV. Similar to bumetanide, furosemide-induced conductance was suppressed by 10 lM clotrimazole as well as 1 mM Ba 2? but not by TEA or 4-AP (n C 2). In the presence of 10 lM clotrimazole, furosemide (30 lM) failed to induced a significant change in whole-cell I/V relation (n = 4).
Bumetanide-Induced Hyperpolarization is Associated with a Surge of Intracellular Ca 2?
Next, we tested the hypothesis that loop diuretics activate a surge of intracellular Ca 2? to indirectly facilitate the IK conductance (Fig. 8) . (Fig. 8A, B) . The [Ca 2? ] i signal often showed spiky fluctuations under both control and stimulated conditions. Typically, the control [Ca 2? ] i signal exhibited a stable level above the extracellular background with a slow rundown likely due to photobleaching, since the rundown speed was associated with the exposure of excitation laser (strength and duration, data not shown). The bumetanide-stimulated surge of signal had a fast onset, reaching its peak about two times the control level in less than 20 s and then slowly decayed afterwards (Fig. 8B) via the internal solution of the recording pipette, the cells all showed a hyperpolarized membrane potential, compared to those recorded with the normal internal solution (Table 1) . In these cells, bumetanide and furosemide failed to induce a hyperpolarization in all cells tested (n = 5, Fig. 8C CFTR-172 (10 lM) -0.5 ± 0.261 4 CFTR blocker [34, 48] Enhanced Cellular Uptake of GTTR by Bumetanide is Inhibited by IK Blockers
Based on these electrophysiological results, we tested the effect of IK channel blockers on bumetanide-enhanced GTTR uptake (Fig. 9) . In the presence of 1 mM Ba 2? or 10 lM clotrimazole, bumetanide was no longer able to enhance cellular GTTR uptake. Interestingly, bumetanide plus clotrimazole or nitrendipine, GTTR fluorescence levels were not lower than those of control cells (GTTR alone; compare to Fig. 5 ), again indicative of a reciprocal antagonism between IK blockers and bumetanide. On the other hand, K
? -channel blockers 10 mM TEA, 4-AP, and 3 lM glipizide and Cl --channel blockers 300 lM DPC, 100 lM NFA, and 10 lM CF172 did not inhibit bumetanide-enhanced GTTR uptake (n = 3-6 in each case).
Gene Expression of Selected TRP Channels, NKCC1, and Na/K-ATPase To identify any possible phenotype changes in the MDCK cells used in this study, gene expression of selected TRP channels, Na ? /K ? /2Cl -cotransporter (NKCC), and Na/K ATPase was determined with RT-PCR (sFig. 6). RNA transcripts of TRPV4, TRPA1, and NKCC1 were detected at high levels. Clear bands for TRPV1, TRPV2, and the alpha-1 subunit of Na ? /K ? ATPase were also detected, although the size of TRPV2 band (*500 bp) was inconsistent with the predicted size of 380 bp. Since the gene sequence information was obtained from the predicted sequence of the dog genome, it is possible that additional bases are inserted in canine TRPV2. A band for TRPV3 was also detected but at a very low level, consistent with its typical expression in neural tissues. The results are consistent with previous reports for MDCK cells [22, 23, 25] .
Discussion
This study sought to clarify the cellular mechanism underlying enhanced cellular uptake of aminoglycosides by loop diuretics. Data showed that application of bumetanide or furosemide increased cellular uptake of GTTR in a dosedependent manner. Moreover, we for the first time demonstrated that bumetanide and furosemide hyperpolarize MDCK cells, increasing the electrical driving force for influx of cationic aminoglycosides through NSCCs. Remarkably, we found that these loop diuretics hyperpolarize the cells mainly, if not solely, via stimulating an increase in cytosolic Ca 2? , thus to activate the intermediate conductance Ca 2? -activated K ? -channels (IK). This is a surprising and novel finding in the pharmacology of these diuretics. that slowly subsided over the 5 min of drug application. Cells with loaded high Ca 2? showed a hyperpolarized membrane potential and became irresponsive to these diuretics. (5) In the presence of clotrimazole or Ba 2? , bumetanide could no longer activate the IK current or enhance GTTR uptake.
These findings add a novel aspect to our understanding of the loop diuretic enhancement of aminoglycoside toxicity, as well as a new pharmacological action of the loop diuretics.
Membrane Potential and Its Determinant Channels in MDCK Cells
It was widely believed that the membrane potential of MDCK cells is determined by K ? and Cl -conductances and their transmembrane concentration gradients [36, 41] . conductance. A Gap-free whole-cell current recorded at a holding potential (HP) -40 mV. The large deflections (1-9) were induced by ramp commands for I/V curve construction. B I/V curves constructed in the absence and presence of bumetanide (BUM; 10 lM) or bumetanide plus 10 lM clotrimazole (CLT). Each curve (a, b, c) was an average of those indicated by numbers in the brackets. Note that the input conductance (G input ) was increased from 0.39 to 0.57 nS and the zero-current potential hyperpolarized from -35 to -47 mV. Adding clotrimazole reversed the bumetanide-induced I/V change to near the control level. C I/V plot of the net current induced by bumetanide alone (Net I -BUM ) and by clotrimazole (Net I -CLT ) in the presence of bumetanide. Note that these two net currents are almost symmetrical (mirror imaged) to the abscissa with a reversal potential near -70 mV, indicating that similar ion currents are off-set when the two drugs are co-applied . A Representative confocal images in the absence (Control) and presence of bumetanide (BUM) taken at the moments indicated by * and ** in B. B Time-lapse plots of the fluo-4 fluorescence intensity ratio (mean ± SE, non-cell background subtracted, n = 52 cells from three plates). C Typical membrane potential recording in 0 current-clamp mode showed that the cell loaded with 2 lM Ca 2? exhibited a hyperpolarized resting membrane potential and little or no voltage responses to 30 lM furosemide (FUR) or 10 lM bumetanide (BUM) (n = 5) Our extended observations show both agreements and discrepancies with previous reports.
First, the cells used in the present study show a 10-20 mV depolarization in response to extracellular exposure to 20 --rich buffer in this study or in the literature [35, 42] . The reason for this discrepancy is not fully understood but the culture duration could be a factor. The cells in this study grown for 24 h in culture dishes rather than 1 week in other studies (e.g., [36] ). Many cells in our experiments were actively proliferating (Fig. 9, sFig. 1 ). It is known that the IK channel plays a key role in cell proliferation [43] and is inversely expressed to the degree of differentiation [44] . We did observe that the IK blocker, clotrimazole, depolarized most cells for up to 32 mV, suggesting a robust background activation of IK in the MDCK cells we used.
Second, previous reports showed that MDCK cells exhibit transcription signals and single channel activity of the TEA-sensitive big conductance Ca 2? -activated K ? channels (BK) [41, 45, 46] . However, we observed only a small (2-4 mV) depolarization by 10 mM TEA in a small portion of cells tested, indicating only a small contribution of this channel to the membrane potential. We did not pursue the reasons for this discrepancy; however, MDCK cells consist of two classes [47] . One class of cells called C7, resembling the principal cells in the kidney collecting duct, expresses very few BK channels, whereas another class of cells called C11, which mimic the intercalated cells, contains abundant BK channels. The MDCK cells used in this study are likely a subclone of the C7 class. Also, single MDCK cells lack cell-cell contact, that might suppress BK expression, as reported previously [48] . Third, in contrast to a report that MDCK type I cells constitutively express functional CFTR channel [49] , we failed to see any membrane potential response to CFTR inh -172, a potent CFTR blocker [34] . Therefore, the channel identity observed here for DPC-and NFA-sensitive Cl -conductance and in earlier studies [35, 42, 50] remain to be clarified. This clarification will be challenging, as determination of the molecular identity responsible for the Cl -conductance has proven to be particularly difficult [51, 52] .
Finally, and most importantly, we demonstrated that La 3? or Gd 3? caused a hyperpolarization in the majority of cells under both conventional intracellular and whole-cell recording conditions (Table 2 ; Fig. 3 ), suggesting a substantial contribution of NSCC conductance to the V m by counteracting the hyperpolarizing K ? current in these cells. It is now known that a large superfamily of channels, the TRP channels, is the mediator of most NSCC currents that sense a variety of physical and chemical stimuli. Indeed, TRPV1, TRPV2, TRPV3, TRPV4, and TRPA1 gene transcripts were identified with TRPV4 and TRPA1 at high levels in the MDCK cells used (sFig. 6). As La 3? and Gd 3? block a number of TRP channel species [53] , the exact induces a hyperpolarization which theoretically increases the driving force for cationic aminoglycoside influx, the La 3? actually inhibits GTTR uptake (Fig. 2) , supporting the conclusion that GTTR influx must substantially go through the La 3? -sensitive channels.
TRP Channels as a Primary Pathway for GTTR Entry into Cells GTTR permeation through mechanotransduction (MET) and TRP channels have been repeatedly demonstrated [13, 20, 22, 23] . However, the permeant mechanism remains unclear as the estimated end-on diameter of GTTR (1.47 nm) is larger than the reported pore size of the hair cell MET (1.25 ± 0.08 nm) [54] and TRP channels (TRPVA1, 1.1-1.38 nm [55] ; TRPV1, *1.0 nm, but may open to 1.4 nm [56] ). One plausible explanation is that channel pore sizes are underestimated. Alternatively, the pores are transiently dilated during GTTR entry [13] ; however, this requires substantiation. Based on our findings and others, we speculate that TRPV4 plays a major role, while TRPA1 and TRPV1 have little, if any, role in mediating GTTR uptake in MDCK cells. TRPA1-encoding mRNA is highly expressed in MDCK cells (sFig. 6). TRPA1 agonists have been demonstrated to mediate GTTR entry into mouse cochlear hair cells even when the MET channels are dysfunctional [20] . However, the TRPA1 channel is normally quiescent at the resting membrane potential until activated by deep cold (\17°C) or pungent agonists [57] . These features suggest that TRPA1 is unlikely to play a significant role in mediating the GTTR influx in these experiments.
The mRNA of TRPV1 is weakly expressed in MDCK cells (sFig. 6), although we have previously reported that GTTR uptake by MDCK cells can be inhibited or enhanced by compounds that modulate TRPV1 channel activity [22] . However, these modulators are no longer considered highly specific for TRPV1 over other TRPV channels [58] . TRPV1 channels are also activated by heat above 43°C, much higher than that in our experiments, and so this channel is unlikely to play a major role in mediating the GTTR uptake.
TRPV4 mRNA is abundantly expressed in MDCK cells (sFig. 6); TRPV4 immunofluorescence was preferentially localized at the basolateral membrane of other kidney epithelial cell-lines, and GTTR uptake is potentiated by TRPV4 overexpression in the kidney cell-lines whereas the TRPV4-dependent GTTR uptake was abolished by a point mutation within the crucial pore region of the channel [23] . TRPV4 is known to be activated by warm temperatures (27-34°C) [57] . Our single channel recording from cellattached patch in MDCK cells in physiological solutions at 22°C revealed a channel activity with characteristics of the TRPV4 channels [59] . These evidences support a major role for TRPV4 in mediating the observed GTTR uptake by MDCK cells. [60] . We believe that the observed hyperpolarization by bumetanide or furosemide was little, if any, related to its inhibition of NKCC. The reasons are four-fold: First, the induced hyperpolarization often showed an abrupt onset, and prolonged application of diuretics did not progressively increase the amplitude of hyperpolarization (Fig. 4) , which is inconsistent with the expected time course of the [Cl -] i change by co-transport inhibition. Second, the induced hyperpolarization was not inhibited by Cl -channel blockers, DPC, NFA, and CFTR inh -172, rather it was suppressed by K ? -channel blockers Ba 2? and IK blocker clotrimazole. Third, the hyperpolarization was associated with an increase, not a decrease, in conductance and with a net current that reversed its polarity at a potential near the calculated E K (-86 mV). Finally, the EC 50s of bumetanide and furosemide for GTTR uptake showed a much smaller difference between bumetanide and furosemide ( Fig. 1) than that reported for NKCC1 inhibition (0.33 vs. 23 lM, [61] ).
In agreement with our observations, Lang e al. [35] observed that a reduction of extracellular [Cl -] to half of the control caused only less than 2 mV depolarization, suggesting that Cl -conductance of subconfluent MDCK cells was small in control conditions. Besides, the possible E Cl negative shift and hyperpolarization due to diureticinduced NKCC inhibition would be counteracted by its concomitant reduction of Na ? influx and the resulting downturn of electrogenic Na ? /K ? -ATPase activity. Therefore, the net change of V m by NKCC1 inhibition is expected to be negligible.
Indirect Mechanism of IK Activation by Bumetanide
We investigated how loop diuretics activate the IK conductance in MDCK cells with a hypothesis based on a previous report [36] . Praetorius et al. [36] reported that gene transcripts for IK channels (K Ca 3.1 or SK4) were detected in MDCK cells, and bending of the primary cilium or mechanically pressing the apical membrane triggers a transient cytosolic Ca (Fig. 8A, B) , and that bumetanide induced a Ba 2? -sensitive hyperpolarization with a long latency. Moreover, loading cells with high Ca 2? (2 lM) abolished loop diuretic-induced hyperpolarization (Fig. 8C) [62] . In this study, a small depolarization preceded bumetanide/furosemide-induced hyperpolarization in some cells (Fig. 4, sFig. 3A ) and the reversal potential of the bumetanide/furosemide-induced net current was consistently 5-10 mV less negative than the calculated E K (Figs. 6, 7 , sFig. 3), suggestive of a concomitant activation of NSCC conductance. Moreover, in the presence of CLT or Ba 2? , bumetanide/furosemide activated a small conductance in I/V, especially in the positive voltage domain (Fig. 7,  sFigs. 3, 6 ). The diuretics-activated net current had a reversal potential near -40 mV, suggesting an activated cation current mixed with a residual K ? -current. In this regard, it is possible that the bumetanide-activated NSCCs may contribute directly to GTTR uptake if the activated NSCCs are GTTR-permeable. However, based on the data shown in Figs. 4, 7, and 9, such direct contribution, if any, should be minimal since 10 lM CLT just completely offset the effect of 10 lM bumetanide on GTTR uptake as well as on the membrane potential.
Taken together, we suggest that loop diuretics may activate some Ca 2? -permeable TRP channels, as a causal step prior to IK activation. Identification of the exact TRP channel species responsible for bumetanide-activated Ca 2? influx/release will be a major challenge since specific blockers for most individual TRP channels have yet to be identified and multiple TRP channels are likely implicated in the cross-membrane traffic of aminoglycosides.
Significance
Here we demonstrated that loop diuretics stimulate a cytosolic Ca 2? surge, thus activate IK channels, hyperpolarize the MDCK cells and then enhance the cellular uptake of GTTR. Beyond this novel action of loop diuretics, our data support the hypotheses that NSCCs, likely TRPV4 channels, are a major aminoglycoside entry pathway into MDCK cells. This cellular mechanism offers a new explanation for the synergistic nephrotoxicity of these two classes of drugs in clinical use [63] . More importantly, as systemically coadministered loop diuretic enhance aminoglycoside levels in endolymph and subsequent ototoxicity [1, 2, 17] , our results represent a potential mechanism of how loop diuretics facilitate aminoglycoside trafficking through the strial BLB. Initially, aminoglycosides must first penetrate through the endothelial cell layer lining the strial capillaries [16, 24] . More than ten TRP channels, including TRPV4, have been identified in vascular smooth muscles and endothelial cells [64] . We have demonstrated that IK and TRP channels are highly expressed in endothelial and smooth muscle cells of cochlear arterioles, which play a key role in vasomotor regulation that controls the cochlear blood flow [38, 65, 66] . It is plausible that this mechanism enables loop diuretics to enhance aminoglycoside loading of the strial vascular endothelium and subsequent clearance into the intrastrial space. Second, strial marginal cells, the single layer of cells between the intrastrial space and endolymph, express TRP channels, especially TRPV4 on their apical (endolymphatic) surface [23, 67] . If functional IK (or SK4, K Ca 3.1) channels are identified in these cells, we expect this cellular mechanism to facilitate aminoglycoside loading of marginal cells, then clearance into endolymph and subsequent uptake by hair cells. These assumptions warrant investigation.
